Screener
Adaptive Biotechnologies ADPT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Common stock: $0.0001 par value, 340,000,000 shares authorized at March 31, 2026 and December 31, 2025; 159,697,221 and 153,779,418 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 16 | 15 |
| Additional paid-in capital | 1,599,708 | 1,581,848 |
| Accumulated other comprehensive (loss) gain | (28) | 253 |
| Accumulated deficit | (1,383,356) | (1,363,323) |
| Total Adaptive Biotechnologies Corporation shareholders’ equity | 216,340 | 218,793 |
| Noncontrolling interest | 7,901 | 6,208 |
| Total shareholders’ equity | 224,241 | 225,001 |
| Total liabilities and shareholders’ equity | $505,943 | $512,736 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Adaptive Biotechnologies's total equity?
- Adaptive Biotechnologies (ADPT) reported total equity of $216.34M in Q1 2026.
- How has Adaptive Biotechnologies's total equity changed year-over-year?
- Adaptive Biotechnologies's total equity increased by 13.6% year-over-year, from $190.42M to $216.34M.
- What is the long-term trend for Adaptive Biotechnologies's total equity?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's total equity has grown at a -21.7% compound annual growth rate (CAGR), from $743.27M to $218.79M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Adaptive Biotechnologies's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude